KRAS Mutation for Staging Resected Non-Small Cell Lung Cancer

J Thorac Oncol. 2019 Jul;14(7):e153-e155. doi: 10.1016/j.jtho.2019.02.023.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma of Lung / diagnosis*
  • Adenocarcinoma of Lung / genetics
  • Adenocarcinoma of Lung / surgery
  • Adenocarcinoma, Mucinous / diagnosis*
  • Adenocarcinoma, Mucinous / genetics
  • Adenocarcinoma, Mucinous / surgery
  • Diagnosis, Differential
  • Female
  • Humans
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / genetics
  • Lung Neoplasms / surgery
  • Middle Aged
  • Mutation*
  • Neoplasms, Multiple Primary / diagnosis*
  • Neoplasms, Multiple Primary / genetics
  • Neoplasms, Multiple Primary / surgery
  • Prognosis
  • Proto-Oncogene Proteins p21(ras) / genetics*

Substances

  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)